Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
H•••••• C•••••• M••••••••• L••
H••••••™ is a New York City-based private equity investment firm focused on middle-market companies across the world of healthcare.
- Class
- Buyout firmprobable, confidence 80%
- Basis
- own website statement
- Size band
- Middle marketdefined by: proxy: $1.47bn Private Equity Fund GAV on the Form ADV filed 2024-03-29
Classification history (2)
- Sep 15, 2026Buyout firm (probable, 80%, cls-pe-2)own website statement“H••••••™ is a New York City-based private equity investment firm focused on middle-market companies across the world of healthcare.”hildred.com
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 11 of 11 distinct vehicles are sworn Private Equity Funds; 10 reported gross assets on a filing in 2022 or later
- Adviser type
- registered investment adviser
- Form ADV filings
- Apr 15, 2019 to Mar 29, 2024
- RAUM
- $1.5Bregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 11
- PE fund GAV, latest filing
- $1.5Breported gross assets (Form ADV), not fund size
- All private fund GAV
- $1.5Bevery private fund type, latest filing
- 2024 PE fund GAV
- $1.5Bsum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2024-03-29, latest gav Private Equity Fund $1.5B, latest counts Private Equity Fund 11, lifetime distinct Private Equity Fund 11
- Employees
- 17
- Headquarters
- New York, NY
- Office address
- 745 FIFTH AVENUE, SUITE 800, New York, NY, 10151-1706
- Business phone
- 646-362-5965
- Sectors
- healthcare
- Geography
- not stated or not yet read
- Revenue
- up to $100M
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- We seek to back exceptional management teams in structurally attractive healthcare sectors that have sizeable market potential, excellent growth prospects, attractive innovation opportunities and manageable pricing trends and competition.
- roles
- add on 4, unknown 12, platform 3
- period
- to 2024-04-30, from 2023-05-02, undated holdings 14, dated observations 10
- window
- last 2024-04-30, first 2023-05-02
- control
- control 4, unknown 15
- companies
- 18
- geography
- count 1, share 0.056, value CT
- investments
- 19
- seller kinds
- unknown 1
- transactions
- 5
- cadence by year
- 2023 add ons 2, other deals 1, 2024 add ons 2
- platform add on
- add ons 4, platforms 3, add ons per platform 1.33
- sector known for
- 3
- disclosed value usd
- n 0
- sector distribution
- count 2, share 0.111, value healthcare services, examples Mountainside Wellness, SportsMed Physical Therapy, count 1, share 0.056, value healthcare it, examples Tebra
- holding period years
- n 0
- repeat counterparties
- role legal adviser, shared 3, entity id 518b747b-9ab8-44db-9ac4-9fbc3cddd863, role co investor, shared 2, entity id e0f036c1-39d2-4380-8078-7613eace12c9, role legal adviser, shared 2, entity id deb21b83-f5c0-4e2a-93eb-3c0ef69d004d
- subsector distribution
- count 2, share 0.111, value physical occupational therapy, examples Mountainside Wellness, SportsMed Physical Therapy, count 1, share 0.056, value healthcare it, examples Tebra
18 companies on the graph (5 transactions); most in healthcare services (2); 3 platforms and 4 add-ons; observed 2023 to 2024
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| H•••••• P•••••••• P••••••• I• L• ADV: Private Equity Fund | buyout or unlabelled | 2024 first reported on Form ADV | $760M as of Mar 29, 2024 | no Form D | Unknown | |
| H•••••• C•••••• C••••••••• L• ADV: Private Equity Fund | Co-investment vehicle | 2023 first reported on Form ADV | $24.7M as of Mar 29, 2024 | no Form D | Early deployment | |
| H•••••• C•••••• C••••••••• L• ADV: Private Equity Fund | Co-investment vehicle | 2022 first reported on Form ADV | $66.7M as of Mar 29, 2024 | no Form D | Early deployment | |
| H•••••• E••••• P••••••• I••••• L• ADV: Private Equity Fund | Buyout fund | 2022 first reported on Form ADV | $58.0M as of Mar 29, 2024 | no Form D | Unknown | |
| H•••••• C•••••• C••••••••• L• ADV: Private Equity Fund | Co-investment vehicle | 2022 first reported on Form ADV | $41.4M as of Mar 29, 2024 | no Form D | Early deployment | |
| H•••••• C•••••• C••••••••• L• ADV: Private Equity Fund | Co-investment vehicle | 2021 first reported on Form ADV | $41.0M as of Mar 29, 2024 | no Form D | Unknown | |
| H•••••• C•••••• C••••••••• L• ADV: Private Equity Fund | Co-investment vehicle | 2021 first reported on Form ADV | $0 as of Mar 29, 2024 | no Form D | Unknown | |
| H•••••• E••••• P••••••• I•• L• ADV: Private Equity Fund | buyout or unlabelled | 2019 first reported on Form ADV | $432M as of Mar 29, 2024 | no Form D | Mature | |
| H•••••• E••••• P••••••• I•••• L• ADV: Private Equity Fund | Buyout fund | 2019 first reported on Form ADV | $23.2M as of Mar 29, 2024 | no Form D | Mature | |
| H•••••• E••••• A••••••••• I•• L• ADV: Private Equity Fund | buyout or unlabelled | 2019 first reported on Form ADV | $9.7M as of Mar 29, 2024 | no Form D | Mature | |
| H•• A••••••••• I• L•• ADV: Private Equity Fund | buyout or unlabelled | unknown | $11.9M as of Mar 29, 2024 | no Form D | Active deployment |
- A••••• G•••••• · Co-Founder and Managing Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- A••••• G•••••• · Co-Founder, Managing Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- A••••• G•••••• · Managing Member · since Jan 1, 2018 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- D•••• S•••••• · Co-Founder, Managing Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- D•••• S•••••• · Managing Member · since Jan 1, 2018 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- A••••••• S•••••• · Managing Director, C••••••• H••••• Strategy · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- B•• S•••• · Managing Director · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- S•••••• H••••••••• · Managing Director · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- S•••••• H••••••••• · Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- W••• F•••• · Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- K•••• R•••• · Principal · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- A••• B••••••••• · Senior Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- B•••• C•• · Vice President of Technology · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- E••••• W•••••• · Senior Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- G•••• N•••• · Vice President · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- I••••• E••••• · Vice President · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- J••••• J••• · Senior Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- S••••••• S••• · Senior Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- B•••• G•••••••• · Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- J•• E••••••• · Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- J•• D•••••• · Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- R••••• P•••• · Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- B••• M•••• · Senior Operating Adviser · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- B•• J•••••• · Operating Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- K•• S••••••••• · Operating Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- R•• H•••• · Operating Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- T•• N•• · Operating Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- A•••••••• A••••• · Investor Relations Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- A••• P• V•••••••• · Vice President of Finance · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- H••••• D••••• · Administrative Assistant · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- K•••• Z••• · Controller · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- M•••• L•••••• · Executive Assistant · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- O••• N•• M•••••••• · Managing Director, Chief Financial Officer & Chief Compliance Officer · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- O••• N•• M•••••••• · Managing Director / Chief Compliance Officer / Chief Financial Officer · since Aug 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- R•••••• R•••••• · Executive Assistant · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- R•••••• S••••• · General Counsel · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- J••• V•••••• · Office Coordinator · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
1 former (kept with end dates)
- B••••••• L••••• · Chief Financial Officer & Chief Compliance Officer · Mar 1, 2019 to Aug 16, 2022 Inference
| Date | Type | Target | This firm’s role | Source |
|---|---|---|---|---|
| Apr 30, 2024 | Add-on acquisition | P••••••• | Sponsor (confirmed) | hildred.com |
| Jan 9, 2024 | Add-on acquisition | M••••••••• W••••••• | Sponsor (confirmed) | hildred.com |
| Oct 24, 2023 | Add-on acquisition | I•••••• U•• H•••••••• L•• | Sponsor (confirmed) | hildred.com |
| Oct 18, 2023 | Add-on acquisition | M••••••••• W••••••• | Sponsor (confirmed) | hildred.com |
| May 2, 2023 | Growth investment | A•••••••• | Sponsor (confirmed) | hildred.com |
- M••••••• G••••• I••• 3 shared · strong · last Jan 1, 2022
- E••••••• G•••• L••••• 1 shared · one time · last Jan 1, 2024
- O••••• F•••••• 1 shared · one time · last Oct 18, 2023
- S••••• 1 shared · one time · last Oct 24, 2023
- L•••••• I••••••••• L•• 1 shared · one time · last Apr 30, 2024
- H•••••• • K••••• 3 shared · strong · last Jan 9, 2024
- S••••• A••••• L•• 2 shared · recurring · last Apr 30, 2024
- K•• G••••• L•• 1 shared · one time · last May 2, 2023
- K••••• L•• 1 shared · one time · last May 2, 2023
- B••••• P••••••• S•••••••• C•••••• 2 shared · recurring · last Apr 30, 2024
- Apr 6, 2026H•••••• C•••••• M••••••••• L••: Private Equity Funds on Form ADV 11 (2024 extract) -> 17 (roster 2026-09-01)
- Oct 8, 2025A•••••••• Appoints Joseph Cosgrove as Chief Executive Officer and Member of the Board of Directors
- Feb 7, 2025Crown Laboratories Completes A••••••••• of R•••••• Therapeutics
- Dec 9, 2024Crown Laboratories and R•••••• Enter into Amended and Restated Merger Agreement
- Sep 16, 2024B•• S•••• Appointed Managing Director at H•••••• Capital Management
- Aug 12, 2024Crown Laboratories and R•••••• Announce Entry Into Merger Agreement
- Apr 30, 2024C••••• C••••••• H••••• Acquires Penetrex from Wellbeam C••••••• H•••••
- Feb 26, 2024W••• F•••• and S•••••• H••••••••• Appointed Partners at H•••••• Capital Management
- Jan 9, 2024S•••••••• P••••••• T•••••• Acquires Red Bank P••••••• T••••••
- Dec 19, 2023Hello Bello Secures Future Growth with Sale to H•••••• Capital Management
- Oct 24, 2023C••••• C••••••• H••••• Acquires I•••••• U•• H•••••••• L••
- Oct 18, 2023S•••••••• P••••••• T•••••• Acquires M••••••••• W•••••••
- Oct 11, 2023Fortune Magazine Names H••••••• N••••••• to 2023 Best Workplaces in Manufacturing & Production List
- May 2, 2023H•••••• Capital Management Completes S•••••••• Investment in A••••••••
- May 2, 2023H•••••• Capital Management Completes S•••••••• Investment in A••••••••
- Oct 20, 2022C••••• C••••••• H••••• names Scott Chapman Chief Executive Officer
- Jul 21, 2022H•••••• Capital Management Appoints O••• M•••••••• Managing Director and Chief Financial Officer
- Jul 12, 2022H•••••• Capital Management Promotes K•••• R•••• to Vice President
- May 24, 2022Crown Laboratories Expands Aesthetics' Portfolio With A••••••••• Of Eclipse Medcorp, Llc Assets
- Feb 22, 2022D••••••• M••••••••• Announces the A••••••••• of Multiple Dermatology Clinics
- Feb 15, 2022H•••••• Capital Management Closes H•••••• Equity Partners II Fund at $363 Million
- Aug 26, 2021Crown Laboratories to Acquire StriVectin®, the #1 Independent Prestige Skincare Company in the U.S.
- May 22, 2019Crown Laboratories Acquires Xycrobe™ Therapeutics, Inc., an Innovator in Skin Microbiome Technology
- Apr 15, 2019H•••••• C•••••• M••••••••• L•• first filed Form ADV in the extract (IA)
- Sep 27, 2018Crown Laboratories Acquires Bellus Medical
H•••••• C•••••• M••••••••• L•• is the same institution as 2 records in Independent Sponsors and RIA and Wealth.
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…